These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 3330253

  • 1. [Evaluation of the effectiveness of gemfibrozil in primary dyslipoproteinemias. II. Relation between the results of treatment and type of dyslipoproteinemia].
    Sznajd J, Malczewska-Malec M, Idzior-Waluś B, Iwanejko J, Nowacki G.
    Przegl Lek; 1987; 44(12):837-43. PubMed ID: 3330253
    [No Abstract] [Full Text] [Related]

  • 2. [Evaluation of the effectiveness of gemfibrozil in primary dyslipoproteinemias. I. Changes in lipid levels after treatment (the "net" reduction)].
    Sznajd J, Malczewska-Malec M, Idzior-Waluś B, Jamska B, Nowacki G.
    Przegl Lek; 1987; 44(12):828-36. PubMed ID: 3330252
    [No Abstract] [Full Text] [Related]

  • 3. Effect of gemfibrozil on serum lipid levels.
    Dahlén G, Gillnäs T, Børresen AL, Berg K, Ericson C.
    Artery; 1980; 7(3):224-31. PubMed ID: 7008748
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Clinical results with gemfibrozil and background to the Helsinki Heart Study.
    Manninen V.
    Am J Cardiol; 1983 Aug 22; 52(4):35B-38B. PubMed ID: 6351578
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Gemfibrozil in the treatment of hyperlipoproteinemias].
    Monova D, Petrova V, Belovezhdov N.
    Vutr Boles; 1991 Aug 22; 30(2):56-8. PubMed ID: 1891900
    [Abstract] [Full Text] [Related]

  • 8. Gemfibrozil plus cholestyramine in familial hypercholesterolaemia.
    Jones AF, Hughes EA, Cramb R.
    Lancet; 1988 Apr 02; 1(8588):776. PubMed ID: 2895309
    [No Abstract] [Full Text] [Related]

  • 9. Gemfibrozil in the treatment of resistant familial hypercholesterolaemia and type III hyperlipoproteinaemia.
    Houlston R, Quiney J, Watts GF, Lewis B.
    J R Soc Med; 1988 May 02; 81(5):274-6. PubMed ID: 3164409
    [Abstract] [Full Text] [Related]

  • 10. Combination drug therapy for familial combined hyperlipidemia.
    East C, Bilheimer DW, Grundy SM.
    Ann Intern Med; 1988 Jul 01; 109(1):25-32. PubMed ID: 3288029
    [Abstract] [Full Text] [Related]

  • 11. Plasma prekallikrein, kallikrein inhibitors, kininogen and lipids during gemfibrozil treatment in type II dyslipidaemia.
    Torstila I, Kaukola S, Manninen V, Virtamo J, Mälkönen M.
    Acta Med Scand Suppl; 1982 Jul 01; 668():123-9. PubMed ID: 6188330
    [Abstract] [Full Text] [Related]

  • 12. Gemfibrozil therapy in primary hypertriglyceridemia associated with coronary heart disease. Effects on metabolism of low-density lipoproteins.
    Vega GL, Grundy SM.
    JAMA; 1985 Apr 26; 253(16):2398-403. PubMed ID: 3856692
    [Abstract] [Full Text] [Related]

  • 13. Gemfibrozil for hyperlipidemia.
    Med Lett Drugs Ther; 1982 Jun 25; 24(612):59-60. PubMed ID: 6953310
    [No Abstract] [Full Text] [Related]

  • 14. Effects of nicotinic acid therapy on high-density lipoprotein metabolism in type II and type IV hyperlipoproteinaemia.
    Packard CJ, Stewart JM, Third JL, Morgan HG, Lawrie TD, Shepherd J.
    Biochim Biophys Acta; 1980 Apr 18; 618(1):53-62. PubMed ID: 6990991
    [No Abstract] [Full Text] [Related]

  • 15. [Effect of bezafibrate therapy on serum and lipoprotein lipids].
    Romics L, Németh Csóka M, Szám I, Pados G, Karádi I, Köszegi G, Kusztos R.
    Orv Hetil; 1986 Oct 05; 127(40):2425-8, 2431. PubMed ID: 3537905
    [No Abstract] [Full Text] [Related]

  • 16. [Plafibride treatment of hyperlipidemias type II and IV].
    Soler J, Vinzia C, Gómez JM, Morató J.
    Med Clin (Barc); 1984 May 19; 82(19):840-2. PubMed ID: 6738212
    [No Abstract] [Full Text] [Related]

  • 17. [Evaluation of the efficiency of gemfibrozil in treating hyperlipidemia type IIb and IV].
    Polakowska M, Broda G, Rywik S, Piotrowski W, Bednarska M, Kuźmińska A, Pytlak A, Chotkowska E.
    Pol Arch Med Wewn; 1994 Jan 19; 91(1):9-18. PubMed ID: 8190659
    [Abstract] [Full Text] [Related]

  • 18. [Indications for and the therapeutic action of hypolipidemic agents in patients with hyperlipoproteinemias].
    Goranov I, Naumova R, Kerekovska M, Balabanski L.
    Vutr Boles; 1987 Jan 19; 26(1):96-101. PubMed ID: 3590738
    [Abstract] [Full Text] [Related]

  • 19. Treatment of hyperlipoproteinemia, types II and IV, with pirifibrate: one hundred observations.
    Bonora V, Calalabuig RJ, Caviola E, Soler J, Pueyo JM, Micaló T, Cano RP.
    Clin Ther; 1981 Jan 19; 4(3):192-200. PubMed ID: 7030489
    [Abstract] [Full Text] [Related]

  • 20. Clinical results with gemfibrozil.
    Pickering JE.
    Am J Cardiol; 1983 Aug 22; 52(4):39B-40B. PubMed ID: 6351579
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.